![Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study - The Lancet Healthy Longevity Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study - The Lancet Healthy Longevity](https://www.thelancet.com/cms/attachment/6fbe3bfe-ece7-438c-be72-c98a86f910ee/gr1_lrg.jpg)
Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study - The Lancet Healthy Longevity
![A year after omicron, North Texas physicians are concerned about COVID's long-term impact | KERA News A year after omicron, North Texas physicians are concerned about COVID's long-term impact | KERA News](https://npr.brightspotcdn.com/09/76/7a44e31e4cc7a1c64aedfdf73cb0/ap22102543039739.jpg)
A year after omicron, North Texas physicians are concerned about COVID's long-term impact | KERA News
![Long Term Effects Of Omicron Variant Largely Unknown, Here's Why You Should Not Take It Lightly - YouTube Long Term Effects Of Omicron Variant Largely Unknown, Here's Why You Should Not Take It Lightly - YouTube](https://i.ytimg.com/vi/WaQCLgz2fNE/mqdefault.jpg)
Long Term Effects Of Omicron Variant Largely Unknown, Here's Why You Should Not Take It Lightly - YouTube
![Milder disease with Omicron: is it the virus or the pre-existing immunity? | Nature Reviews Immunology Milder disease with Omicron: is it the virus or the pre-existing immunity? | Nature Reviews Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41577-022-00678-4/MediaObjects/41577_2022_678_Fig1_HTML.png)
Milder disease with Omicron: is it the virus or the pre-existing immunity? | Nature Reviews Immunology
![Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study | The BMJ Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study | The BMJ](https://www.bmj.com/content/bmj/378/bmj-2022-071502/F1.medium.jpg)
Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study | The BMJ
![Understanding the Post COVID-19 Condition (Long COVID) in Adults and the Expected Burden for Ontario - Ontario COVID-19 Science Advisory Table Understanding the Post COVID-19 Condition (Long COVID) in Adults and the Expected Burden for Ontario - Ontario COVID-19 Science Advisory Table](https://covid19-sciencetable.ca/wp-content/uploads/2022/09/Table-1.png)
Understanding the Post COVID-19 Condition (Long COVID) in Adults and the Expected Burden for Ontario - Ontario COVID-19 Science Advisory Table
![COVID-19 infections increase risk of long-term brain problems – Washington University School of Medicine in St. Louis COVID-19 infections increase risk of long-term brain problems – Washington University School of Medicine in St. Louis](https://medicine.wustl.edu/wp-content/uploads/Long-Covid-Brain1.jpg)
COVID-19 infections increase risk of long-term brain problems – Washington University School of Medicine in St. Louis
![Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study - The Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study - The](https://www.thelancet.com/cms/attachment/8dcbb478-cb1f-4e58-bc54-3ff1743bf560/gr1.jpg)
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study - The
![SARS-CoV-2 Omicron variant: recent progress and future perspectives | Signal Transduction and Targeted Therapy SARS-CoV-2 Omicron variant: recent progress and future perspectives | Signal Transduction and Targeted Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-022-00997-x/MediaObjects/41392_2022_997_Fig1_HTML.png)